S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BioSpecifics TechnologiesMersana TherapeuticsAnaptysBioBeyondspringProgenics Pharmaceuticals
SymbolNASDAQ:BSTCNASDAQ:MRSNNASDAQ:ANABNASDAQ:BYSINASDAQ:PGNX
Price Information
Current Price$54.47$5.26$14.93$12.34$3.15
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$90.00$13.00$53.57$29.67$12.00
% Upside from Price Target65.23% upside147.15% upside258.82% upside140.41% upside280.95% upside
Trade Information
Market Cap$391.03 million$238.05 million$408.90 million$291.06 million$278.85 million
Beta1.011.710.881.152.16
Average Volume66,249553,400679,65050,2731,241,186
Sales & Book Value
Annual Revenue$38.19 million$42.12 million$8 millionN/A$34.99 million
Price / Sales10.475.6750.87N/A7.80
Cashflow$3.50 per shareN/AN/AN/AN/A
Price / Cash15.58N/AN/AN/AN/A
Book Value$16.96 per share$1.64 per share$14.93 per share($0.42) per share$0.54 per share
Price / Book3.213.211.00N/A5.83
Profitability
Net Income$24.47 million$-28,210,000.00$-97,340,000.00$-54,870,000.00$-68,550,000.00
EPS$3.33($0.65)($3.60)($2.42)($0.80)
Trailing P/E Ratio16.41N/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins64.08%-66.97%N/AN/A-195.94%
Return on Equity (ROE)21.56%-27.93%-22.34%N/A-106.04%
Return on Assets (ROA)21.14%-21.78%-20.92%-248.61%-48.40%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.06%N/A0.16%1.01%
Current Ratio76.84%4.21%12.79%3.61%2.89%
Quick Ratio76.84%4.21%12.79%3.61%2.89%
Ownership Information
Institutional Ownership Percentage63.32%78.05%N/A7.21%75.97%
Insider Ownership Percentage16.39%29.20%14.00%N/A4.26%
Miscellaneous
Employees68678N/A79
Shares Outstanding7.34 million45.43 million27.26 million25.96 million86.60 million
Next Earnings Date5/8/2020 (Estimated)5/14/2020 (Estimated)5/5/2020 (Estimated)7/8/2020 (Estimated)5/14/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel